Former Bucknell University strength and conditioning coach Mark Kulbis has been charged in connection with the July 2024 death of freshman football player Calvin “CJ” Dickey Jr. The charges follow a collapse during a training session, highlighting critical safety protocols regarding athletes diagnosed with the sickle-cell trait (SCT).
In Plain English: The Clinical Takeaway
- Sickle-Cell Trait (SCT) vs. Disease: SCT is an inherited condition where a person carries one gene for sickle-cell disease. Unlike the disease, carriers usually remain asymptomatic but face risks under extreme physiological stress, such as intense anaerobic exercise.
- Exertional Sickling: High-intensity training can cause red blood cells to change from a flexible, round shape into a rigid, “sickle” shape. These cells can block blood flow, leading to rapid muscle breakdown (rhabdomyolysis) and potential organ failure.
- Prevention is Mandatory: Safety guidelines for athletes with SCT require gradual acclimation to training, immediate access to hydration, and the ability to rest whenever symptoms arise.
The Pathophysiology of Exertional Sickling
The tragedy involving CJ Dickey Jr. underscores the lethal potential of “exertional sickling,” a condition where the physical demands of elite athletics overwhelm the body’s compensatory mechanisms. When an athlete with SCT performs at maximum capacity, the resulting lactic acid buildup and systemic hypoxia (low oxygen levels) in the blood create an environment where hemoglobin molecules polymerize. This causes red blood cells to stiffen and assume a crescent shape.
Unlike standard muscle fatigue, this process leads to microvascular occlusion—the physical blocking of small blood vessels. As noted by the National Athletic Trainers’ Association (NATA), this is not a respiratory issue but a hemodynamic crisis. When blood flow is obstructed to muscle tissue, the resulting ischemia (lack of blood supply) can trigger rhabdomyolysis, where muscle fibers rapidly break down and release myoglobin into the bloodstream, potentially leading to acute kidney injury and cardiac arrhythmias.
Regulatory Oversight and Institutional Accountability
In the United States, the NCAA mandates that all Division I student-athletes undergo sickle-cell trait testing or provide proof of prior status. Following the 2010 consensus statement—often referred to as the “National Athletic Trainers’ Association Position Statement on Sickle Cell Trait”—universities are required to implement specific safety protocols. These include allowing athletes with SCT to set their own pace during conditioning and ensuring that medical staff are trained to recognize the symptoms of sickling, which often mimic heat exhaustion but require different clinical intervention.
Dr. Francis Collins, former director of the National Institutes of Health (NIH), has previously emphasized that while SCT is common—affecting approximately 8% to 10% of African Americans—the transition from a carrier state to a clinical emergency is preventable through rigorous adherence to “intensity-limiting” protocols. The charges against Kulbis focus on the alleged failure to adhere to these standardized safety measures during the 2024 training session.
| Condition | Mechanism | Primary Risk |
|---|---|---|
| Sickle-Cell Trait (SCT) | Heterozygous (one gene) | Exertional Rhabdomyolysis |
| Sickle-Cell Disease | Homozygous (two genes) | Vaso-occlusive Crisis |
Contraindications & When to Consult a Doctor
Athletes with a known diagnosis of SCT must be managed with extreme caution. There are no “contraindications” to exercise per se, but there are strict contraindications to maximal-intensity, unacclimated training. If an athlete experiences muscle cramping that feels different from a standard “charley horse”—specifically if the pain is deep, associated with extreme fatigue, or if the athlete feels they “cannot go on”—this is a medical emergency.
Symptoms such as dark, tea-colored urine, sudden muscle weakness, or a rapid onset of breathing difficulties during exercise require immediate cessation of activity and urgent evaluation by medical personnel. If you carry the trait, consult a sports medicine physician to develop a structured, evidence-based conditioning plan that prioritizes graduated intensity.
The Future of Athlete Safety
The legal proceedings against the former Bucknell coach serve as a stark reminder of the intersection between clinical guidelines and institutional practice. Public health experts have long argued that medical protocols are only as effective as their implementation on the field. As researchers continue to study the long-term cardiovascular impacts of SCT, the focus remains on the “non-negotiables” of sports medicine: hydration, gradual acclimation, and the empowerment of athletes to stop training when their body signals distress.
References
- Centers for Disease Control and Prevention: Sickle Cell Trait Information
- National Athletic Trainers’ Association: Consensus Statement on Sickle Cell Trait in Athletes
- NCAA: Sickle Cell Trait Guidance and Policy
Disclaimer: This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
